Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-09-17

Clinical Trial Update: A Protocol for the Safety and Tolerance of Intravenous Isophosphoramide Mustard (IPM) in Patients With Advanced Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study protocol evaluated the safety and tolerability of intravenous Isophosphoramide Mustard in patients with advanced cancer; the trial status is com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Isophosphoramide Mustard (Isophosphoramide Mustard)

Snippet

Sponsor: Alaunos Therapeutics | Conditions: Advanced Cancer | Phase 1 | Status: COMPLETED